Pseudoginsenoside-F11 is primarily studied for its neuroprotective properties. It has shown potential in improving cognitive function and memory, making it a subject of interest in research on neurodegenerative disorders such as Alzheimer's disease. The compound appears to modulate neurotransmitter systems and reduce oxidative stress in brain tissues, which may help protect neurons from damage. It also exhibits anti-inflammatory effects in the central nervous system, contributing to its overall neuroprotective profile. Additionally, Pseudoginsenoside-F11 has been investigated for its role in reducing symptoms of depression and anxiety in preclinical models, suggesting possible applications in mental health support. Its ability to cross the blood-brain barrier enhances its effectiveness as a candidate for brain-targeted therapies.